{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:37:55Z","timestamp":1790642275399,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T00:00:00Z","timestamp":1742774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T00:00:00Z","timestamp":1742774400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Johann Wolfgang Goethe-Universit\u00e4t, Frankfurt am Main"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Weight change for women living with HIV (WLWH) who receive dolutegravir (DTG) is understudied around pregnancy. The aim of this study was to investigate the direction and magnitude of weight change among WLWH pre-, during, and post-gestation based on DTG exposure history.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This retrospective cohort study evaluated adult pregnant WLWH receiving antenatal care between 2016 and 2022 at two clinics in Nigeria and followed them over three 9-month periods (pregestational, antenatal, and postgestational). Patients were stratified into three DTG exposure groups for each follow-up period: non-DTG, DTG-switch, and DTG. Three mixed effects models with random intercepts and slopes were utilized to assess the association between DTG and weight. Sensitivity analysis was conducted using binomial DTG exposure with starting time.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The study included 2386 women, 851 (35.7%) of whom used DTG at some point. Average maternal weight was 63.8\u2009\u00b1\u200912.7\u00a0kg, 67.0\u2009\u00b1\u200913.1\u00a0kg, and 64.5\u2009\u00b1\u200912.7\u00a0kg during the pregestational, antenatal, and postgestational period. The weight difference in kg for DTG and DTG-switch compared to other ARTs were 0.06 (-1.66, 1.79) and -2.11 (-5.33, 1.11) pregestational, -0.613 (-2.14, 0.92) and 1.21 (-0.80, 3.21) antepartum, and 2.64 (0.37, 4.91) and 0.89 (-1.40, 3.18) postgestational. The antenatal slope (\u03b2) for DTG exposure and initiation time was 0.01 (0.001, 0.02) kg\/day.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>DTG therapy is associated with more rapid weight gain during pregnancy without significantly affecting the total weight gained. Moreover, retained weight postgestation is higher in women on DTG. Therefore, they could face higher future metabolic and cardiovascular risks.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12981-025-00731-x","type":"journal-article","created":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:19:53Z","timestamp":1742861993000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Patterns of peri-gestational weight change among women living with HIV in Nigeria receiving dolutegravir compared to alternative antiretroviral regimens: a retrospective cohort study"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5345-4688","authenticated-orcid":false,"given":"Ammar","family":"Al Naimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly","family":"Rawizza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluwaseun","family":"Olaifa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olabanjo","family":"Ogunsola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prosper","family":"Okonkwo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phyllis","family":"Kanki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,24]]},"reference":[{"issue":"10","key":"731_CR1","doi-asserted-by":"crossref","first-page":"e633","DOI":"10.1016\/S2352-3018(21)00152-1","volume":"8","author":"D Jahagirdar","year":"2021","unstructured":"Jahagirdar D, Walters MK, Novotney A, Brewer ED, Frank TD, Carter A, et al. Global, regional, and national sex-specific burden and control of the HIV epidemic, 1990\u20132019, for 204 countries and territories: the global burden of diseases study 2019. Lancet HIV. 2021;8(10):e633\u201351.","journal-title":"Lancet HIV"},{"issue":"8","key":"731_CR2","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/hiv.13120","volume":"22","author":"KN Mmasa","year":"2021","unstructured":"Mmasa KN, Powis K, Sun S, Makhema J, Mmalane M, Kgole S, et al. Gestational diabetes in women living with HIV in Botswana: lower rates with dolutegravir- than with efavirenz-based antiretroviral therapy. HIV Med. 2021;22(8):715\u201322.","journal-title":"HIV Med"},{"issue":"1","key":"731_CR3","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12977-022-00608-1","volume":"19","author":"AV Zhao","year":"2022","unstructured":"Zhao AV, Crutchley RD, Guduru RC, Ton K, Lam T, Min AC. A clinical review of HIV integrase strand transfer inhibitors (INSTIs) for the prevention and treatment of HIV-1 infection. Retrovirology. 2022;19(1):22.","journal-title":"Retrovirology"},{"issue":"8","key":"731_CR4","doi-asserted-by":"crossref","first-page":"e534","DOI":"10.1016\/S2352-3018(22)00173-4","volume":"9","author":"TR Malaba","year":"2022","unstructured":"Malaba TR, Nakatudde I, Kintu K, Colbers A, Chen T, Reynolds H, et al. 72 weeks post-partum follow-up of dolutegravir versus efavirenz initiated in late pregnancy (DolPHIN-2): an open-label, randomised controlled study. Lancet HIV. 2022;9(8):e534\u201343.","journal-title":"Lancet HIV"},{"key":"731_CR5","unstructured":"Panel on Treatment of HIV During Pregnancy and Prevention of Perinatal Transmission. Recommendations for the Use of Antiretroviral Drugs During Pregnancy and Interventions to Reduce Perinatal HIV Transmission in the United States. . https:\/\/clinicalinfo.hiv.gov\/en\/guidelines\/perinatal2022."},{"key":"731_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ph15121533","author":"EG Foster","year":"2022","unstructured":"Foster EG, Gendelman HE, Bade AN. HIV-1 integrase strand transfer inhibitors and neurodevelopment. Pharmaceuticals (Basel). 2022. https:\/\/doi.org\/10.3390\/ph15121533.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"4","key":"731_CR7","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.25484","volume":"23","author":"K Bourgi","year":"2020","unstructured":"Bourgi K, Jenkins CA, Rebeiro PF, Palella F, Moore RD, Altoff KN, et al. Weight gain among treatment-na\u00efve persons with HIV starting integrase inhibitors compared to non-nucleoside reverse transcriptase inhibitors or protease inhibitors in a large observational cohort in the United States and Canada. J Int AIDS Soc. 2020;23(4): e25484.","journal-title":"J Int AIDS Soc"},{"issue":"9","key":"731_CR8","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1056\/NEJMoa1902824","volume":"381","author":"WD Venter","year":"2019","unstructured":"Venter WD, Moorhouse M, Sokhela S, Fairlie L, Mashabane N, Masenya M, et al. Dolutegravir plus two different prodrugs of tenofovir to treat HIV. N Engl J Med. 2019;381(9):803\u201315.","journal-title":"N Engl J Med"},{"issue":"9","key":"731_CR9","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1056\/NEJMoa1904340","volume":"381","author":"Group NAS","year":"2019","unstructured":"Group NAS. Dolutegravir-based or low-dose efavirenz\u2013based regimen for the treatment of HIV-1. N Engl J Med. 2019;381(9):816\u201326.","journal-title":"N Engl J Med"},{"key":"731_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-022-00726-5","author":"A Alebel","year":"2022","unstructured":"Alebel A, Sibbritt D, Petrucka P, Demant D. Association between body mass index variation and early mortality among 834 Ethiopian adults living with HIV on ART: a joint modelling approach. Infect Dis Ther. 2022. https:\/\/doi.org\/10.1007\/s40121-022-00726-5.","journal-title":"Infect Dis Ther"},{"issue":"3","key":"731_CR11","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/EDE.0000000000000629","volume":"28","author":"SC MacDonald","year":"2017","unstructured":"MacDonald SC, Bodnar LM, Himes KP, Hutcheon JA. Patterns of gestational weight gain in early pregnancy and risk of gestational diabetes mellitus. Epidemiology. 2017;28(3):419\u201327.","journal-title":"Epidemiology"},{"issue":"21","key":"731_CR12","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1001\/jama.2017.3635","volume":"317","author":"RF Goldstein","year":"2017","unstructured":"Goldstein RF, Abell SK, Ranasinha S, Misso M, Boyle JA, Black MH, et al. Association of gestational weight gain with maternal and infant outcomes: a systematic review and meta-analysis. JAMA. 2017;317(21):2207\u201325.","journal-title":"JAMA"},{"issue":"4","key":"731_CR13","first-page":"339","volume":"201","author":"AM Siega-Riz","year":"2009","unstructured":"Siega-Riz AM, Viswanathan M, Moos M-K, Deierlein A, Mumford S, Knaack J, et al. A systematic review of outcomes of maternal weight gain according to the Institute of Medicine recommendations: birthweight, fetal growth, and postpartum weight retention. Am J Obstet Gynecol. 2009;201(4):339.","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"731_CR14","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/obr.12288","volume":"16","author":"J Marchi","year":"2015","unstructured":"Marchi J, Berg M, Dencker A, Olander E, Begley C. Risks associated with obesity in pregnancy, for the mother and baby: a systematic review of reviews. Obes Rev. 2015;16(8):621\u201338.","journal-title":"Obes Rev"},{"key":"731_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2020.100615","author":"EC Caniglia","year":"2020","unstructured":"Caniglia EC, Shapiro R, Diseko M, Wylie BJ, Zera C, Davey S, et al. Weight gain during pregnancy among women initiating dolutegravir in Botswana. EClinicalMedicine. 2020. https:\/\/doi.org\/10.1016\/j.eclinm.2020.100615.","journal-title":"EClinicalMedicine"},{"key":"731_CR16","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1472-6874-9-10","volume":"9","author":"M Lof","year":"2009","unstructured":"Lof M, Hilakivi-Clarke L, Sandin SS, de Assis S, Yu W, Weiderpass E. Dietary fat intake and gestational weight gain in relation to estradiol and progesterone plasma levels during pregnancy: a longitudinal study in Swedish women. BMC Womens Health. 2009;9:10.","journal-title":"BMC Womens Health"},{"key":"731_CR17","doi-asserted-by":"publisher","DOI":"10.1160\/pamjs.supp.2014.18.1.4608","author":"A Bashorun","year":"2014","unstructured":"Bashorun A, Nguku P, Kawu I, Ngige E, Ogundiran A, Sabitu K, et al. A description of HIV prevalence trends in Nigeria from 2001 to 2010: what is the progress, where is the problem? Pan Afr Med J. 2014. https:\/\/doi.org\/10.1160\/pamjs.supp.2014.18.1.4608.","journal-title":"Pan Afr Med J"},{"issue":"3","key":"731_CR18","doi-asserted-by":"crossref","first-page":"e671","DOI":"10.1093\/cid\/ciac609","volume":"76","author":"B Chaplin","year":"2023","unstructured":"Chaplin B, Agbaji O, Reyes Nieva H, Olatunde B, Chang C, Mitruka K, et al. Timeliness of point-of-care viral load results improves human immunodeficiency virus monitoring in Nigeria. Clin Infect Dis. 2023;76(3):e671\u201380.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"731_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4102\/ajlm.v4i1.190","volume":"4","author":"DJ Hamel","year":"2015","unstructured":"Hamel DJ, Sarr AD, Meloni ST, Kanki PJ, Samuels JO, Ofuche E, et al. Building laboratory capacity to support HIV care in Nigeria: Harvard\/APIN PEPFAR, 2004\u20132012. Afr J Lab Med. 2015;4(1):1\u201310.","journal-title":"Afr J Lab Med"},{"issue":"9","key":"731_CR20","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1097\/CM9.0000000000001972","volume":"135","author":"A Yin","year":"2022","unstructured":"Yin A, Tian F, Wu X, Chen Y, Liu K, Tong J, et al. Excessive gestational weight gain in early pregnancy and insufficient gestational weight gain in middle pregnancy increased risk of gestational diabetes mellitus. Chin Med J (Engl). 2022;135(9):1057\u201363.","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"731_CR21","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/QAI.0000000000003101","volume":"92","author":"FJ Palella","year":"2023","unstructured":"Palella FJ, Hou Q, Li J, Mahnken J, Carlson KJ, Durham M, et al. Weight gain and metabolic effects in persons with HIV who switch to ART regimens containing integrase inhibitors or tenofovir alafenamide. J Acquir Immune Defic Syndr. 2023;92(1):67\u201375.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"731_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27249057","author":"AJ Theron","year":"2022","unstructured":"Theron AJ, Anderson R, Madzime M, Rossouw TM, Steel HC, Meyer PWA, et al. Pro-inflammatory interactions of dolutegravir with human neutrophils in an in vitro study. Molecules. 2022. https:\/\/doi.org\/10.3390\/molecules27249057.","journal-title":"Molecules"},{"key":"731_CR23","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13908","author":"G Gilberti","year":"2025","unstructured":"Gilberti G, Tiecco G, Marconi S, Marullo M, Zanini B, Quiros-Roldan E. Weight gain, obesity, and the impact of lifestyle factors among people living with HIV A systematic review. Obes Rev. 2025. https:\/\/doi.org\/10.1111\/obr.13908.","journal-title":"Obes Rev"},{"key":"731_CR24","doi-asserted-by":"crossref","unstructured":"Committee A. ACOG Committee opinion no. 548: weight gain during pregnancy. Obstet Gynecol. 2013;121 1: 210\u20132","DOI":"10.1097\/01.AOG.0000425668.87506.4c"},{"issue":"1","key":"731_CR25","doi-asserted-by":"crossref","first-page":"2166400","DOI":"10.1080\/14767058.2023.2166400","volume":"36","author":"GF Milone","year":"2023","unstructured":"Milone GF, Tiwari M, McLnerney HJ, Franz B, Chappelle J, Persad MD, et al. Does a video module improve patient adherence to recommended gestational weight gain guidelines? J Matern Fetal Neonatal Med. 2023;36(1):2166400.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"6","key":"731_CR26","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/GCO.0b013e328332d24e","volume":"21","author":"KM Rasmussen","year":"2009","unstructured":"Rasmussen KM, Catalano PM, Yaktine AL. New guidelines for weight gain during pregnancy: what obstetrician\/gynecologists should know. Curr Opin Obstet Gynecol. 2009;21(6):521\u20136.","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"5","key":"731_CR27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0252247","volume":"16","author":"S Gebremedhin","year":"2021","unstructured":"Gebremedhin S, Bekele T. Gestational weight gain in sub-Saharan Africa: Estimation based on pseudo-cohort design. PLoS ONE. 2021;16(5): e0252247.","journal-title":"PLoS ONE"}],"container-title":["AIDS Research and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-025-00731-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12981-025-00731-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-025-00731-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:20:29Z","timestamp":1742862029000},"score":1,"resource":{"primary":{"URL":"https:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-025-00731-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,24]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["731"],"URL":"https:\/\/doi.org\/10.1186\/s12981-025-00731-x","relation":{},"ISSN":["1742-6405"],"issn-type":[{"value":"1742-6405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,24]]},"assertion":[{"value":"15 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by two Review Boards and patient\u2019s consent for data use in research was provided.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"38"}}